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Abstract
Background: The appropriate time to initiate enteral nutrition after the placement of a percutaneous endoscopic
gastrostomy (PEG) tube has been an area of limited research. There are no sufficient randomised prospective
controlled trials in the paediatric population comparing the safety and tolerance of early feeding (3 h) after PEG
placement. In order to reduce the period of fasting, inadequate nutritional support, and hospitalisation time, we
decided to devise this study.
Methods/Design: This study is a multicentre, randomised, open-label trial designed to evaluate the tolerance and
safety of early enteral nutrition after PEG placement in children. Patients are randomised to receive the first feeding
bolus with a polymeric diet (1 kcal/ml) via a feeding tube 3 h after the PEG placement (group I - early enteral feeding)
or 8 h after the procedure (group II - late enteral feeding). The key objective of the study is to compare the tolerance
and safety of the early- and late-feeding modes after PEG placement in children. The primary endpoint is the number
of patients who will achieve full feed (total fluid and caloric requirements) within 48 h of the first feeding bolus. The
secondary endpoints are: the number of early and late complications, the duration of hospitalisation after PEG
placement, gastric residuals (ml) total in the period up to 48 h since the first feeding bolus.
Discussion: To our knowledge this is the first study in paediatric patients to evaluate the tolerance and safety of early
enteral nutrition after PEG placement. The goal is to establish an optimum standard procedure in the group
of paediatric patients qualified for the PEG insertion procedure in Poland.
Trial registration: ClinicalTrials.gov ID NCT02777541, registration date 05/18/2016.
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Background
The percutaneous endoscopic gastrostomy (PEG) tech-
nique for gastrostomy placement was developed as an
alternative to surgical placement with the advantage of
faster recovery. Although the benefits and techniques for
the insertion of PEG have been described and accepted,
feeding after PEG placement is not as clear. Tradition-
ally, tube feedings have been delayed after PEG place-
ment to the next day and up to 24 h postprocedure.
This decision is based on a standard convention, extrap-
olated from surgical guidelines, with little data to sup-
port the withholding of feedings after PEG placement.
Over the past 15 years, many studies have examined the
use of early PEG feedings after insertion. Results from
various randomised controlled trials (RCTs), mostly in
adults, indicate that earlier feeding might be an option.
In some adult centres, it is reported that the procedure
can be performed in the morning and the patient dis-
charged the same day. Despite the recent literature indi-
cating early PEG feedings as a safe alternative, the
common practice continues to be to significantly delay
post-PEG feedings. It is essential, especially in children,
to reduce to a minimum fasting time and begin to im-
prove nutritional status as soon as possible. In view of the
financial pressures on the healthcare system, the economic
aspect is also essential. A short stay in hospital can be
beneficial for both the medical centre and the child, and it
could result in reducing the overall cost of the procedure.
There are only a few studies on the safety of early
feeding after PEG placement in paediatric patients. The
recent prospective randomised study with the earliest
feeding in children after PEG placement is by Corkins et
al. [1]. Forty successive patients who met the entry cri-
teria were enrolled, with 20 in each group, and they
found no increase in complications with the earliest
feeding (3 h after PEG insertion).
Our study will include a relatively large group of pa-
tients (100, 50 in each group), and the observation will
last 12 months, which is longer than in other studies.
First of all we would like to determine whether earlier
initiation of feeds (3 h after PEG placement) is as effect-
ive and well tolerated as the current standard practice
(8 h) and result in shortening the length of stay in hos-
pital after PEG implantation. Both the objectives of the
study and the primary, secondary and tertiary endpoints,
are described in detail below. The goal is to establish an
optimum standard procedure in the group of paediatric
patients qualified for PEG insertion procedure.
Methods
Study design
This study is a multicentre, randomised, open label trial de-
signed to evaluate the tolerance and safety of early enteral
nutrition after PEG placement in children. Recruitment will
be from patients attending one of six medical centres in
Poland: The Department of Gastroenterology, Hepatol-
ogy and Feeding Disorders and The Department of
Paediatrics, Nutrition and Metabolic Disorders, The
Children’s Memorial Health Institute in Warsaw, The
Department of Paediatrics, Gastroenterology, Hepatol-
ogy and Nutrition, The Medical University in Gdańsk,
The Department of Allergology, Gastroenterology and
Nutrition, The Medical University in Łódź, The Depart-
ment of Paediatrics, The Medical University of Silesia
in Katowice and The Department of Paediatrics and
Gastroenterology, The Area Hospital in Toruń.
The trial will include 100 patients, from 1-month-olds
to 18-year-olds, qualified for PEG placement. All partici-
pants will be prepared for the procedure according to
the standard medical protocol.
Parents/legal guardians, and where possible also the
patient, will be informed about the research plan, and after
signed informed consent to participate in the study, pa-
tients will be enrolled on the study. At the Baseline visit
participants will be randomised (1:1) to one of two treat-
ment groups: Group I-the early enteral feeding group (3 h
after PEG implantation) or Group II - the late enteral feed-
ing group (8 h after PEG implantation). Follow-up visits in
hospital are planned 3, 6, 9 and 12 months after the proced-
ure in all subjects.
Ethics
All the procedures are reviewed and approved by the
Independent Review Board (Komisja Bioetyczna IP CZD,
Approval Number: 73/KBE/2013). Patients and their
caregivers will give their written informed consent before
the start of any procedure.
The study will be conducted in accordance with the
protocol, International Conference on Harmonization
(ICH) guidelines, the applicable regulations and guide-
lines governing the conducting of clinical studies, and
the ethical principles that have their origin in the Declar-
ation of Helsinki.
The investigator or his/her representative will explain
the nature of the study to the subject and the subject’s
parent/legal guardian, and answer all questions regard-
ing this study. The subjects will be included in all dis-
cussions in order to obtain verbal or written assent.
Prior to any study-related procedures being performed
on the subject, the informed consent statement will be
reviewed and signed and dated by the subject’s parent/
legal guardian and the person who administered the
informed consent.
The selection of the study population
Subjects will be screened to determine whether they
meet all the inclusion criteria specified below and have
none of the exclusion criteria of this protocol.
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The Inclusion Criteria are: age between 1 month and
18 years, medical indications for PEG placement, and in-
formed consent to participate in the study signed and
dated by the subject’s parent/legal guardian and also by
the patient over the age of 16 years. Patients will be ex-
cluded if they: have serious, uncorrectable coagulation
disorders, there is an inability to perform upper gastro-
intestinal (UGI) endoscopy (laryngeal or oesophageal
stricture), or there is need for concomitant fundoplica-
tion or lack of technical ability to perform PEG place-
ment procedure.
Objectives
The main/primary objective of the study is to compare the
tolerance of the early and late feeding modes after percu-
taneous gastrostomy placement in children.
The secondary objectives of the study are: to confirm
the safety of early enteral nutrition after PEG implant-
ation, to analyse the correlation between the feeding
mode and the occurrence of early or late complications
after the procedure and to compare the length of stay in
hospital between two analysed groups.
Additionally, we would like to establish the impact of
several factors (nutritional status, oropharyngeal flora, gas-
troesophageal reflux (GER), vitamin and trace element de-
ficiency, faecal calprotectin level), on the complication rate
and the PEG nutrition results. Apart from that we would
like to establish the impact of PEG implantation on GER.
Endpoints
The primary endpoint is the number of patients who will
achieve full feed (total fluid and caloric requirements)
within 48 h since the first feeding bolus.
The secondary endpoints are: the number of early
complications (up to 6 days after PEG placement), the
number of late complications (7 days-12 months after
PEG placement), the duration of hospitalisation after
PEG placement (in days), gastric residuals (ml) - total in
the period up to 48 h since the first feeding bolus.
Tertiary endpoints are: improvements in nutritional
status (3, 6, 9, 12 months after the procedure), body
weight gain (kg) and height gain (cm), BMI kg/m2, the
influence of vitamin and trace element deficiency, bio-
chemical parameter abnormalities in the complications
rate, the influence of ghrelin, leptin and adiponectin
level on nutritional status improvement after PEG place-
ment, the influence of gastroesophageal reflux (GER) di-
agnosed before the procedure on feeding tolerance, the
correlation between the faecal calprotecine level and
feeding tolerance after PEG placement, the complication
rate and nutritional status before PEG placement, the
influence of oropharymgeal flora on the complications
rate (wound infection) and the correlation between PEG
placement and GER.
Randomisation
Subjects with clinical indications for percutaneous gas-
trostomy placement will be centrally randomised into one
of the maintenance protocols: early enteral feeding-3 h
after PEG placement (Group I) or late enteral feeding-8 h
after PEG placement (Group II).
It was not possible to blind the nursing staff to the
feeding time assigned to each patient.
Intervention
All subjects will be prepared for the procedure according
to established protocol, consistent with the actual ESP-
GHAN and ESPEN recommendations. Study procedures
are listed below. Subjects will be fasted for 6 h before
the procedure, where the child is only breast-fed, for
4 h. All subjects will receive one dose of intravenous
antibiotic before the placement: Augmentin 30 mg/kg,
in the case of hypersensitivity to beta lactam antibiotics:
Clindamycin 3–6 mg/kg +Metronidazole 10 mg/kg. All
the participants will receive primary gastrostomy button
placement by the standard “pull” technique under gen-
eral anaesthesia, using the Flocare PEG tube (Nutricia).
Tissue samples from the stomach and duodemum will
be obtained during the endoscopic examination for ce-
liac disease screening. The severity of oesophagitis will
be classified according to the Los Angeles Classification.
The procedure will be performed under general anaes-
thesia and afterwards patients will recover in a general
post-anaesthesia-care area approximately for 2–3 h. Sub-
jects will follow the same postoperative care, accordance
with the standard established schedule. The postopera-
tive procedures are introduced in Table 1.
Resumption of feeding
The first feeding (Group I-3 h after the procedure,
Group II-8 h after the procedure) will be with a poly-
meric diet (1 kcal/ml). The first feeding portion will have
a volume equal to 1/3 of the full recommended portion,
the volume of the second feeding will be equal to 2/3 of
the full recommended portion and the third portion will
be equal to the full recommended portion. Each portion
will be introduced through the enteral feeding pump
(Flocare Infinity, Nutricia), for 30 min, with a three-hour
break between feeds (Scheme 1). The infusion of a 5 %
glucose solution with electrolytes will be given through
an intravenous line to cover the maintenance fluid
requirements in all subjects.
Study procedures
The study procedures are discussed in detail in this sec-
tion. All study data will be recorded in documents. Sub-
jects will be screened to ensure they meet all the inclusion
criteria and none of the exclusion criteria. The patients
and their caregivers will give their written informed
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consent before the start of any procedure. All subjects will
undergo a radiological examination of upper gastrointes-
tinal tract at screening. 24-h oesophageal pH monitoring/
Multi-Channel Intraluminal Impedance and pH Measure-
ment will be obtained at screening and after 10–12
months. A qualified physician will interpret the study re-
sults. Vital Signs-blood pressure, heart rate, respiratory
rate, body temperature-will be monitored during hospitali-
sations. All measurements will be recorded in metric units
when applicable. A physical examination, including weight
and height, will be performed at each visit. Abnormalities
noted will be evaluated and documented by the investiga-
tor as to whether they are complications. Oropharyngeal
flora will be determined before PEG insertion at screening
in all subjects. The microbiological flora will be examined
in the event of wound infection in all subjects. Samples
will be obtained for the laboratory tests. Clinical labora-
tory tests are listed in Table 2. All abnormal laboratory
test results that are considered clinically significant by the
investigator will be followed up to a satisfactory reso-
lution. Plasma ghrelin, lepitin and adiponectin levels will
be measured in all subjects after 72 h of enteral nutritional
feeding (two measurements-fasting and 2 h after feeding).
Test for faecal calprotectin level will be made in all sub-
jects at screening. In all subjects the serum anti-tissue
transglutaminase (tTG-IgA) and total IgA serum level will
be measured for celiac-disease screening. Anthropometric
parameters-height, weight, BMI, arm circumference, tri-
ceps skinfold and mean length of forearm-will be con-
trolled during the study. Dietary consultation will be
performed at screening and at control visits planned dur-
ing the study. Complications will be monitored through-
out the entire study period. Data on all study participants
will be included in the safety analyses. At each visit, data
about complications will be documented and blood sam-
ples will be obtained for laboratory evaluation. Any with-
drawals from the study due to complications will be
recorded in the study documentation. To evaluate paren-
tal/caregiver degree of satisfaction with the gastrostomy
feeding the structured Satisfaction Questionnaire with
Gastrostomy Feeding, the SAGA-8 questionnaire, will be
used 6 months after the PEG implantation. To investigate
the influence of PEG placement on the family quality of
life at Baseline Visit and 12 months after PEG implant-
ation the validated Family Quality of Life Questionnaire
ver. 2006 will be used.
Complications
Complications will be monitored throughout the entire
study period. Data on all study participants will be in-
cluded in the safety analyses. At each visit, complications
will be documented and blood samples will be obtained
for laboratory evaluation, and microbiological flora will
be examined in the event of wound infection.
The occurrence of complications up to 6 days after
PEG placement was considered as early complications.
The occurrence of complications from 7 days to
12 months after the PEG placement was considered as
Scheme 1 Feeding regimen after PEG insertion
Table 1 The postoperative procedures
First Day after procedure • The first change of dressing - morning after PEG placement
• The wound area is inspected (bleeding, erythema, secretion, induration, allergic skin reaction etc.),
cleaned, disinfected and dried completely.
• The tube should be pushed approximately 2–3 cm ventrally and carefully pulled back up to the
resistance of the internal fixation flange.
• Y-compress is applied under the tube
• The external fixation plate is secured with free movement of at least 5 mm
• Sterile dressing is applied
To 7 Days after the procedure • Sterile dressing performed everyday
• The wound area is inspected (bleeding, erythema, secretion, induration, allergic skin reaction etc.),
cleaned, disinfected and dried completely.
7-14 Days after the procedure • Sterile dressing performer every few days
• The wound area is inspected (bleeding, erythema, secretion, induration, allergic skin reaction etc.),
cleaned, disinfected and dried completely.
• Washing with soap and water or showering is possible after initial wound healing
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late complications. Complications after PEG placement
included: death < 72 h, vomiting, nausea, regurgitations,
gastric residuals volume ≥ than in the previous feeding
bolus (ml), GERD, aspiration pneumonia, diarrhoea,
fever, bleeding from the gastrointestinal tract, local infec-
tion (reddening around the stoma canal, granulation tissue
around the stoma, bleeding from the stoma canal, peristo-
mal abcess), leakage of gastric contents, enlargement of
the stoma canal, gastrointestinal cutaneous fistula, occlu-
sion of the PEG tube, damage to the PEG tube, dislocation
of the PEG system, buried bumper syndrome.
Protocol deviations
The investigator should not implement any deviation from
the protocol without prior review and agreement by Study
supervision and in accordance with the Ethics Committee.
Determination of sample size
Assuming the probability of an event in the control
group of 0.6 and the probability of an event in the ex-
perimental group of 0.85, control per case subject 1, 0.8
statistical power, 0.05 alpha coefficient, the required size
of each group was estimated at 50 (100 in total) with the
Chi-square test.
Planned methods of statistical analysis
The primary endpoints will include the ratio of patients
who achieved full feed (liquid/calories) within 48 h of
the first feeding bolus. The appropriate Chi-square tests
will be used to compare the frequencies of primary end-
points, depending on the expected numbers. The
intention to treat (ITT) analysis will include the deter-
mination of the proportions of patients with the primary
endpoint achieved.
Secondary endpoints will include gastric residuals
(total up to 48 h), the complications ratio, the duration
of hospitalisation. The appropriate Chi-square tests for
quality variables and the U Mann-Whitney test for
quantity variables will be used.
Tertiary endpoints: the impact of nutritional status for
PEG nutrition results: the appropriate Chi-square tests
and uni- and multivariate analyses will be used.
Percutaneous endoscopic gastrostomy (PEG) was in-
troduced for the first time in 1980 by Gauderer and
Ponsky, and since that time the procedure has been
modified and improved several times. PEG has become
the preferred method for providing long term enteral
nutrition in children with insufficient oral intake [2].
Discussion
Percutaneous endoscopic gastrostomy (PEG) was intro-
duced for the first time in 1980 by Gauderer and Ponsky,
and since that time the procedure has been modified and
improved several times. PEG has become the preferred
method for providing long-term enteral nutrition in
children with insufficient oral intake. The optimal timing
for gastrostomy placement remains uncertain; it varies
between 2 and 12 weeks of enteral feeding depending on
recommendations [3–5]. According to the current ESP-
GHAN recommendations the anticipated duration of en-
teral nutrition exceeding 4–6 weeks [6] is an indication for
gastrostomy and it can be prolonged in many cases. Before
PEG placement each case should be considered on its own
merits. the advantages and disadvantages must be assessed
by a multidisciplinary nutrition-support team, taking into
account clinical condition, diagnosis, prognosis, ethical is-
sues, patients’ and parents’ expectations and expected ef-
fect on the quality of the child’s life. In general, PEG can
Table 2 Clinical laboratory tests
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be used as a means of exclusive or supplemental enteral
tube feeding, gastric decompression and/or the adminis-
tration of medications [7]. It can significantly reduce feed-
ing time, improve nutritional status and growth, and also
the social functioning or quality of life [8, 9]. The range of
indications for PEG tube use is wide and has been demon-
strated in children with neurodisability, congenital heart
disease, cystic fibrosis, neonatal pulmonary disease, onco-
logical disorders, metabolic disease, genetic-chromosomal
and degenerative disease, Crohn’s disease and chronic
renal failure [10]. The former indication for PEG place-
ment is dysphagia associated with neurological or neuro-
muscular disorders, especially cerebral palsy [11].
The appropriate time to initiate enteral nutrition after
the placement of a percutaneous endoscopic gastros-
tomy (PEG) tube has been an area of limited research.
Historically, data to guide decisions regarding the initi-
ation of feedings has been extrapolated from surgical
experience with gastrostomy tubes. The recommended
time for the resumption of feeding in adults and chil-
dren is inconsistent, and varies from 1 to 24 h [5]. There
are few published trials in the literature to guide post-
PEG feeding decisions. Choudhry et al. prospectively
analysed 41 subjects in a randomised controlled fashion
to early (after 3 h) versus delayed feedings (after 24 h)
after PEG placement [12]. Two subjects in the early
intervention group versus one subject in the late inter-
vention group had feedings held due to significant
gastric residuals (arbitrarily defined significant gastric
residual volumes as 60 mL). Complication rates and
mortality data were similar among the groups. Stein et
al. prospectively enrolled 80 patients in a randomised
controlled trial comparing immediate feeding within one
hour after PEG placement versus feeding after 24 h in
intensive care and intermediate unit patients [13]. Gas-
tric residual volumes were measured as the primary end-
point. Residual volumes were similar between groups on
days 1 and 3. Complication rates and mortality rates
were similar between groups. Brown et al. prospectively
enrolled 57 patients in a controlled randomised trial
comparing early (within 3 h) versus a delayed (next-day)
feeding regimen post PEG-placement [14]. All patients
tolerated the feeding regimen without complication.
Chumley et al. describes in abstract form a prospective
randomised controlled study of 150 patients [15]. Three
groups were compared. Groups 1 and 2 were fed early
(Group 1, n = 50 — fed at 3 h; Group 2, n = 50 — fed at
6 h). Delayed feedings took place after 24 h. Only one
patient in the 3-h group developed increased gastric
residuals (volume not defined). McCarter et al. prospect-
ively studied 112 patients in a controlled randomised
fashion comparing early feedings (4 h) versus delayed
feeding (24 h) after PEG placement [16]. Twenty five
percent of the early feeding group had a high gastric
residual on day 1 compared to 9 % in the delayed feeding
group (p = <0.029). By day two, there was not a statistically
significant difference in gastric residuals between the
groups. One patient in the study died of aspiration pneu-
monia (delayed-feeding group). Minor complications were
similar between the groups. In 2008 Bechtold et al. per-
formed meta-analysis and only RCTs on adult subjects
that compared early (≤4 h) versus delayed or next-day
feedings after PEG placement were included [17]. Authors
concluded that early feeding can represent a safe alterna-
tive to delayed or next-day feedings. Although an increase
in significant gastric residual volumes at day 1 was noted,
overall complications were not affected. Szary et al. in
2011 in their meta-analysis demonstrated that feeding ini-
tiated 3 h after PEG placement in adult patients is safe
and effective [18]. By initiating feeding earlier after PEG
placement, many patients can avoid acute care hospital
stays, unnecessarily prolonged intravenous access and
medications and receive earlier substantial nutrition. The
study evaluating the safety of early (6 h) feeding in chil-
dren after PEG placement (6 h) was performed by Werlin
et al. [19]. This was an uncontrolled series of 24 paediatric
patients, and they found no increase in the complication
rate with the earlier feedings. The recent prospective ran-
domised study with earliest feeding in children after PEG
placement is by Corkins et al. [1]. Forty successive patients
who met the entry criteria were enrolled, with 20 in each
group. The authors compared the tolerance of feedings at
3 and 6 h after percutaneous endoscopic gastrostomy
placement. The change in abdominal girth before and 1 h
after the initial feeding, any vomiting, and the gastric re-
sidual volume before the next feeding. were recorded and
the length of stay was also documented. They found no
increase in complications with the earliest feeding (3 h
after PEG insertion).
Concluding, there aren’t sufficient randomised pro-
spective controlled trials in the paediatric population
comparing the safety and tolerance of early feeding after
PEG placement (3–4 h). Most patients are fasted for at
least 12 h following percutaneous endoscopic gastros-
tomy. In order to decrease the period of fasting, inad-
equate nutritional support, and hospitalisation time, we
decided to design this study. The additional goal is to es-
tablish an optimum standard procedure in the group of
paediatric patients qualified for PEG insertion procedure
in Poland.
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